【論文】 再発・治療抵抗性AMLに対してex vivo screeningを行い、その結果に応じて治療を決定した臨床試験の論文読んだ。 今更読んだ理由は最近出た寛解導入時のスクリーニングと治療効果を比較した論文で、薬剤感受性とMRDがほぼ関連しておらず、 https://t.co/Mmk4zpkn7P https://t.co/6lyrjIxBlA
We touch on a number of articles in the show, including https://t.co/3XiKtrr8UQ and https://t.co/5TWsvel00l, which showcase how precision medicine can be implemented against AML and multiple myeloma. Thanks to both our guests for being so generous with th
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #FunctionalPrecisionMedicine Tumor Board for Acute Myeloid #Leukemia @DishaMalani @Wenn…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #FunctionalPrecisionMedicine Tumor Board for Acute Myeloid #Leukemia @DishaMalani @Wenn…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #FunctionalPrecisionMedicine Tumor Board for Acute Myeloid #Leukemia @DishaMalani @Wenn…
ICYMI in @CD_AACR: Implementing a #FunctionalPrecisionMedicine Tumor Board for Acute Myeloid #Leukemia @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka https://t.co/cBVYBrv5h1 @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst #ASH22 https:/
Therapies should be based on response properties of tumors, not transcriptome pt 3: https://t.co/fGY8egHl8o
Therapies should be based on response properties of tumors, not transcriptome pt 2: https://t.co/RozdQi1yE7
Important study on functional ex vivo drug testing to guide clinical decisions: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia https://t.co/sRL2eBLqX4
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
RT @precisiondiagn4: RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board... #leukemia by @DishaMa…
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board... #leukemia by @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst https://t.co/iHCHYmybQH https:/
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
Congratulations, fantastic work
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
@TheSFPM
RT @CD_AACR: From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @…
From the February issue: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia by @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst https://t.co/hSd0QMwv6p https
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia [Research Articles] https://t.co/ndaO1raBf7 https://t.co/oZy8UqaQU5
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia https://t.co/ksuC3NEdwL
RT @imedverse: Online First | Cancer Discovery💐 Implementing a Functional #Precision #medicine #Tumor Board for Acute Myeloid #leukemia.…
Online First | Cancer Discovery💐 Implementing a Functional #Precision #medicine #Tumor Board for Acute Myeloid #leukemia. #AML @CD_AACR @imedverse https://t.co/nSTg7nO6kA https://t.co/VKgQzDZ27A
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
RT @kporkka: Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10…
Thank you for highlighting our paper @ElizSMcKenna implicating the potential of functional precision medicine in R/R AML. >10 years of work by a large group supertalented scientists & clinicians. And lots of fun. @TheSFPM @EHA_Hematology
RT @ElizSMcKenna: ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @Wenn…
ICYMI in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst https://t.co/cBVYBrv5h1
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
Amazing work from Olli Kallioniemi Lab from OnkPat @karolinskainst on successful functional ex vivo drug testing in #AML https://t.co/nCDPg4ReWc
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
RT @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @Wen…
Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia. https://t.co/wcpd7HwCBO @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst https://t.co/AhgwTjE9Ta
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
RT @NatRevClinOncol: In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and re…
In a prospective study involving multi-omics profiling in 186 pts with AML, actionable drugs were found for 97% and recommendations implemented in 37 w R/R disease, with an ORR of 59%, including 13 CRs and brinding to aHSCT in 5 pts https://t.co/tmuZcacskc
RT @ElizSMcKenna: Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani…
RT @ElizSMcKenna: Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani…
RT @ElizSMcKenna: Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani…
RT @ElizSMcKenna: Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani…
RT @ElizSMcKenna: Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani…
RT @DrTonyLetai: @TheSFPM the hits keep coming!
@TheSFPM the hits keep coming!
Implementing a functional #precision #medicine #tumor #board for acute myeloid leukemia (#AML) https://t.co/o0wX8KO6Ra
Now online in @CD_AACR: Implementing a #functionalprecisionmedicine tumor board for acute myeloid #leukemia @DishaMalani @WennerbergLab @HeckmanLab @OKallioniemi @kporkka @helsinkiuni @FIMM_UH @iCAN_Finland @karolinskainst https://t.co/cBVYBrv5h1
Led by Dr. Kimmo Porkka (@kporkka), scientists at the University of Helsinki (@helsinkiuni) generated ex vivo drug response and multi-omics profiling data for a prospective series of 252 samples from 186 acute #myeloid #leukemia patients. Read it here! 🔬
Implementing a functional precision medicine tumor board for acute myeloid leukemia https://t.co/g08eDDJ6lQ
Implementing a functional precision medicine tumor board for acute myeloid leukemia #HelsinkiHealth #tutkimus #tiede https://t.co/5Xh6KsirTB
New article: Implementing a functional precision medicine tumor board for acute myeloid leukemia https://t.co/XAPHgTFXI8 #AML #leusm #hematology https://t.co/S7awIkqae9
The results were published in Cancer Discovery, a top-tier cancer journal: https://t.co/xjLO2krbw4